drugset / Trial / NCT00165490

Combination Chemotherapy, Radiation Therapy and Surgery for Esophageal Cancer

NCT00165490 ↗

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to find out what effects (good and bad) the combination of three chemotherapy drugs (cetuximab, cisplatin, and irinotecan) have on esophageal cancer when given with radiation therapy.

Timeline

Start
2004-08
Primary completion
2007-11
Completion
2014-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Cetuximab Monoclonal antibody — Intravenous
Subject Cisplatin Other / unclassified — —
Subject Irinotecan Small molecule — —